Clinical Trials

Accrual Status
Limit to SWOG Trials

1030 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0601 NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL 8/15/2006 6/1/2008 100% Published
    Closed SWOG-437 NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer 1/19/1970 53%
    Closed S0629 Observational and Phase II WM w/ Trans. & Maint. for Symptomatic WM 9/15/2008 0%
    Closed S0120 Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders 6/1/2002 4/1/2011 97% Published
    Closed S1612 Older AML 12/22/2017 5%
    Closed S0341 OSI-774/PS 2/selected Stage IIIB or IV NSCLC 9/15/2004 10/1/2005 100% Published
    Closed S9701 OVARIAN 11/15/1997 12/1/2001 62% Published
    Closed S9912 OVARIAN 10/1/2000 8/15/2005 100% Published
    Closed S0009 OVARIAN 3/15/2001 2/1/2006 100% Published
    Closed S0211 Ovarian 4/15/2002 1/1/2006 77% Published
    Closed S0200 OVARIAN 8/15/2002 12/15/2004 6% Published
    Closed S0025 OVARIAN 2/15/2003 8/15/2003 5%
    Closed S9700 PANCREAS 9/15/1997 6/19/2001 90% Published
    Closed S9924 PANCREAS 6/1/2000 6/1/2001 97% Published
    Closed S0107 PANCREAS 7/1/2001 6/1/2003 100% Published
    Closed S0727 Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 3/1/2008 9/1/2010 100% Published
    Closed S0205 PANCREATIC 1/1/2004 4/1/2006 100% Published
    Closed S1107 Papillary Renal, ARQ 197 +/- Erlotinib, Ph II 8/20/2012 5/29/2014 71%
    Open S2001 Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects 12/4/2020 59%
    Closed S0437 PCPT Long Term Follow Up 9/1/2005 3/1/2009 53%
    Scroll Table